These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6134650)
1. Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Lins PE; Wajngot A; Adamson U; Vranic M; Efendić S Diabetes; 1983 Jul; 32(7):633-6. PubMed ID: 6134650 [TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man. Ward WK; Halter JB; Best JD; Beard JC; Porte D Diabetes; 1983 Oct; 32(10):943-7. PubMed ID: 6137430 [TBL] [Abstract][Full Text] [Related]
3. The influence of graded hyperglycemia with and without physiological hyperinsulinemia on forearm glucose uptake and other metabolic responses in man. Jackson RA; Hamling JB; Blix PM; Sim BM; Hawa MI; Jaspan JB; Belin J; Nabarro JD J Clin Endocrinol Metab; 1986 Sep; 63(3):594-604. PubMed ID: 2874153 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia. Klaff LJ; Taborsky GJ Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057 [TBL] [Abstract][Full Text] [Related]
5. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Baron AD; Schaeffer L; Shragg P; Kolterman OG Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs. Sakurai H; Dobbs R; Unger RH J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439 [TBL] [Abstract][Full Text] [Related]
7. Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. Sherwin RS; Tamborlane W; Hendler R; Saccá L; DeFronzo RA; Felig P J Clin Endocrinol Metab; 1977 Nov; 45(5):1104-7. PubMed ID: 925134 [TBL] [Abstract][Full Text] [Related]
8. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog. Altszuler N; Gottlieb B; Hampshire J Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672 [TBL] [Abstract][Full Text] [Related]
9. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686 [TBL] [Abstract][Full Text] [Related]
10. Restoration of stable metabolic conditions during islet suppression in dogs. Bradley DC; Bergman RN Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903 [TBL] [Abstract][Full Text] [Related]
11. Altered ability of the liver to produce glucose following a period of glucagon deficiency. Deri JJ; Williams PE; Steiner KE; Cherrington AD Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181 [TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700 [TBL] [Abstract][Full Text] [Related]
13. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man. Ward WK; Best JD; Halter JB; Porte D J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177 [TBL] [Abstract][Full Text] [Related]
14. Effects of morphine on glucose homeostasis in the conscious dog. Radosevich PM; Williams PE; Lacy DB; McRae JR; Steiner KE; Cherrington AD; Lacy WW; Abumrad NN J Clin Invest; 1984 Oct; 74(4):1473-80. PubMed ID: 6148357 [TBL] [Abstract][Full Text] [Related]